Vulvar vestibulitis syndrome: an overview of non-surgical treatment.
Vulvar vestibulitis syndrome, which represents one of the major cause of dyspareunia, is a puzzling clinical entity. Although many treatment options have been employed, a rationale therapeutic strategy is still not stated. The present article reviews the most popular medical approaches of such entity (biofeedback, tricyclic antidepressants, interferon psychologic-behavioural therapy, diet modification), as well as those to avoid. Tricyclic antidepressants and biofeedback of the pelvic floor muscles represents the first line effective therapy. Moreover, psychological counselling must support any treatment options.
Mariani
L
L
Deptartment of Gynecologic Oncology, Regina Elena Cancer Institute of Rome, Via Elio Chianesi, 53, 00144, Rome, Italy. luciorm@libero.it
D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D001676:Biofeedback, Psychology; D005260:Female; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D014847:Vulvitis / Q000178:diet therapy / Q000209:etiology / Q000523:psychology* / Q000628:therapy*
D000929:Antidepressive Agents, Tricyclic; D007372:Interferons